Matthias Wirth

Charité Universitätsmedizin Berlin Campus Benjamin Franklin

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Wolfgang Sippl

Professor

Martin Luther University Halle-Wittenberg

GERMANY

View details

Markus Schick

GERMANY

View details

Zonera Hassan

Klinikum rechts der Isar der Technischen Universität München

GERMANY

View details

Ulrich Keller

Prof. Dr.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Oliver H. Krämer

GERMANY

View details

Stefan Müller

Goethe University Frankfurt

GERMANY

View details

Christine Klement

Technical University of Munich

GERMANY

View details

Dieter Saur

Technical University of Munich

GERMANY

View details

Francis Baumgartner

Charité - Universitätsmedizin Berlin

GERMANY

View details

Günter Schneider

GERMANY

View details

Michael Linnebacher

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthias Wirth

Research Interests

Explore related searches

Contact this professor

Articles (10)

NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor

Actionable loss of SLF2 drives B‐cell lymphomagenesis and impairs the DNA damage response

Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseases

Finding the straw that breaks the cancer's back?

Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.

Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition

HDAC2 Facilitates Pancreatic Cancer Metastasis

A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer.

AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer.

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.

Collaborators (11)

Wolfgang Sippl

Markus Schick

Zonera Hassan

Ulrich Keller

Oliver H. Krämer

Stefan Müller

Christine Klement

Dieter Saur

Francis Baumgartner

Günter Schneider

Michael Linnebacher

Make your next move.